Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,463 total articles

NOVAGOLD Files Third Quarter 2026 Report Unlocking Donlin Gold’s Full Potential and Advancing the Path To Development

NOVAGOLD Files Third Quarter 2026 Report Unlocking Donlin Gold’s Full Potential and Advancing the Path To Development

NOVAGOLD Resources Inc. announced definitive agreements to acquire Paulson Advisers' 40% interest in Donlin Gold LLC, increasing NOVAGOLD's stake to 100%, making Donlin Gold a wholly-owned project. The acquisition is expected to close by year-end 2026, pending shareholder and regulatory approvals. The company continues to advance the Bankable Feasi…

Gold.com’s Spectrum Wine Acquires Wine Cellar Club, Expanding Storage Capacity to Approximately 125,000 Cases

Gold.com’s Spectrum Wine Acquires Wine Cellar Club, Expanding Storage Capacity to Approximately 125,000 Cases

Gold.com, Inc., through its majority-owned subsidiary Spectrum Wine Auctions LLC, has acquired Wine Cellar Club, increasing its professional wine storage capacity to approximately 1.5 million bottles across multiple U.S. and Hong Kong facilities. This acquisition positions Spectrum Wine as one of the largest professional wine storage operators in t…

General Fusion Achieves World-First 1 keV Electron Temperature Milestone on its Path to Commercial Fusion Power

General Fusion Achieves World-First 1 keV Electron Temperature Milestone on its Path to Commercial Fusion Power

General Fusion Group Ltd. announced achieving a world-first plasma electron temperature exceeding 12 million degrees Celsius (1 keV) using their Magnetized Target Fusion technology on their LM26 demonstration machine. This milestone validates their practical and economical approach to fusion energy, marking progress on their roadmap toward commerci…

Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors

Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors

Aardvark Therapeutics, a Nasdaq-listed clinical-stage biopharmaceutical company developing novel small-molecule therapeutics for metabolic diseases, has appointed David Zhang, Ph.D., MBA, as an independent director to its Board. Dr. Zhang brings over 25 years of experience in clinical strategy, biostatistics, and regulatory submissions from leading…

ROC Launches SaaS Product, Establishes Foundation for New Recurring Revenue Opportunities for its Vision AI Portfolio

ROC Launches SaaS Product, Establishes Foundation for New Recurring Revenue Opportunities for its Vision AI Portfolio

Rank One Computing Corporation (ROC), a U.S. Vision AI leader, launched its first SaaS product, the Age Estimation API, enabling developers direct and real-time access to its facial age estimation technology. This strategic move initiates ROC's plan to broaden its revenue base by offering additional SaaS and API solutions in facial analytics and bi…

Amneal to Report Third Quarter 2026 Results on November 3, 2026

Amneal to Report Third Quarter 2026 Results on November 3, 2026

Amneal Pharmaceuticals announced it will release its third quarter 2026 financial results before market open on November 3, 2026. The company will host a live audio webcast for investors. Amneal is a diversified biopharmaceutical firm with a portfolio including generics, specialty, and biosimilars, servicing largely the U.S. market.

World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Quantum BioPharma Ltd. announced the consolidation of its direct action lawsuit with a class action alleging stock price manipulation against Canadian banks CIBC and RBC. The U.S. District Court in New York appointed Grant & Eisenhofer as lead counsel for the class action. The lawsuits claim the defendants engaged in 'spoofing' to manipulate Quantu…

Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting

Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting

Entera Bio Ltd., a clinical-stage biotechnology company specializing in oral peptide therapies, announced an additional late-breaking presentation at the ASBMR 2026 Annual Meeting detailing the Phase 3 clinical trial design for EB613, their oral anabolic osteoporosis treatment candidate. The Phase 3 trial will be a randomized, double-blind, placebo…

Phathom Pharmaceuticals to Present New Data and Analyses for VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting

Phathom Pharmaceuticals to Present New Data and Analyses for VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting

Phathom Pharmaceuticals announced it will present three scientific posters featuring new analyses of its drug VOQUEZNA® (vonoprazan) at the American College of Gastroenterology (ACG) 2026 Annual Scientific Meeting. These presentations include efficacy across BMI subgroups, real-world patient characteristics, and cost-effectiveness in erosive esopha…

Byrna Technologies Reports Fiscal Third Quarter 2026 Results

Byrna Technologies Reports Fiscal Third Quarter 2026 Results

Byrna Technologies Inc. reported fiscal Q3 2026 results showing a 46% year-over-year revenue decline to $15.3 million, primarily due to lower e-commerce sales and slower reorder activity. However, gross profit margin improved significantly to 79% including a one-time tariff refund, or about 65% adjusted. The company completed the acquisition of HER…